Clinical Trials Logo

Clinical Trial Summary

The laying of a naso-gastric tube is an extremely common event in intensive medicine; although standard naso-gastric tube laying is performed at the patient's bedside, this procedure is not without risk. Through the use of methods already used in the clinical field, of daily use, we want to identify the threshold value between tracheal and esophageal etCO2 (group A) and the threshold value between gastric and esophageal pH (group B).


Clinical Trial Description

Numerous methodologies have been evaluated to recognize the correct positioning of NGT at the gastric level, including different clinical techniques (such as gastric auscultation, aspiration of the NGT), ultrasound techniques, etc. Actually, the diagnostic gold standard is the thoraco-abdominal anterior-posterior radiography, which is considered the only non-invasive method capable to confirm the correct pose of the NGT at intra-diaphragmatic level. This method, however, even if it is non-invasive, requires the use of ionizing radiation (4 micro-Sievert (uSv) for radiography) which could be repeated multiple time for the same patient; NGT may need to be repositioned several times during the same hospital stay, increasing patient exposure to ionizing radiation and, potentially, also the health workers exposure. The aim is to identify into the group A the threshold value between tracheal and esophageal etCO2 and into the group B the theshold value between gastric and esophageal pH. Phase A: etCO2 measurement will be collected 1. after intubation, when the tube is inserted into the endotracheal tube, before proceeding with the aspiration of secretions and 2. once the NGT has been inserted, by a probe located at the end of the tube. Phase B: pH measurement will be collected at the end of the procedure, once the NGT is inserted, at 1.a distance of 25 cm from the mouth (oesophageal site) and at 2. a distance of 40 cm (gastric site), aspirating the gastric contents and measuring on specific litmus paper. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03934515
Study type Observational
Source Clinica Luganese Moncucco
Contact
Status Completed
Phase
Start date November 1, 2020
Completion date August 1, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06122597 - A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body. N/A
Not yet recruiting NCT05852145 - Oral Changes With Caloric and no Caloric Sweeteners Phase 1/Phase 2
Completed NCT03526770 - Comparison of 5 Buffering Agents on Changes in Salivary pH in Individuals Previously Exposed to a Test Carbonated Drink N/A
Completed NCT03513575 - Comparison of 5 Buffering Agents on Changes in Salivary pH in Individuals Previously Exposed to a Test Flavoured Milk N/A
Completed NCT03612414 - Efficacy of a Dietary Supplement (Aqualief®) in Xerostomic Patients N/A
Not yet recruiting NCT03877874 - The Impact of Anti- Asthmatic Medications on Salivary pH and Dental Caries Pattern in a Group of Egyptian Children With Bronchial Asthma
Completed NCT05437874 - Carbonated Beverage Consumption in pH and Bacterial Proliferation Phase 1
Completed NCT04717778 - Comparison of Salivary pH After Consuming Milk of Origin Vegetable vs Cow's Milk in Children N/A
Completed NCT01338571 - Horton & Maizy Pilot Study for Resistant to Starch N/A
Completed NCT05746949 - Comparison of the Effects of High-flow Nasal Cannula Oxygen and Jet Ventilation Techniques N/A
Completed NCT03510962 - Comparison of 5 Buffering Agents on Changes in Salivary pH in Individuals Previously Exposed to a Test Fruit Juice N/A